Lack of evidence for erythema multiforme in skin reaction to adalimumab: comment on the article by Beuthien et al.
Meyer
Nicolas
N
Paul
Carle
C
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003951:Diagnostic Errors; D004892:Erythema Multiforme / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology*; D005076:Exanthema / Q000473:pathology*; D006801:Humans; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab